Human tissue kallikrein gene family: A rich source of novel disease biomarkers

Expert Review of Molecular Diagnostics

Volumn 1, Issue 2, 2001, Pages 182-190

  Diamandis, Eleftherios P ^a   Yousef, George M ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Alzheimers disease; Breast cancer; Cancer biomarkers; Diagnostic tests; Kallikrein genes; Ovarian cancer; Prostate cancer; Secreted protiens; Serine proteases; Tumor markers

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; HUMAN GLANDULAR KALLIKREIN 1; HUMAN STRATUM CORNEUM CHYMOTRYPTIC ENZYME; HUMAN STRATUM CORNEUM TRYPTIC ENZYME; KALLIKREIN; KALLIKREIN 2; PANCREATIC KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN EMSP1; PROTEIN NES1; PROTEIN TADG14; RENAL KALLIKREIN; SERINE LIKE PROTEASE; SERINE PROTEINASE; TRYPSIN LIKE SERINE PROTEASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BREAST CANCER; CHROMOSOME 19Q; DIAGNOSTIC VALUE; DISEASE MARKER; DNA SEQUENCE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; OVARY CANCER; PROGNOSIS; PROSTATE CANCER; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0035557506     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.1.2.182     Document Type: Review

References (59)

1. The human kallikrein gene family - Implications in carcinogenesis
2. The human tissue kallikrein gene family: Structure, function and association to disease
3. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4
4. The expanded human kallikrein gene family: Locus characterization and molecular cloning of a new member, KLK-L3 (KLK9)
5. The molecular biology of the kallikreins and their roles in inflammation
6. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4
7. Identification and molecular characterization of a novel member of the Siglec family (SIGLEC-9)
8. Molecular characterization of siglec-8 variant containing cytoplasmic tyrosine-based motifs and mapping of a siglec-8 gene
9. Sialic acid binding receptors (siglecs) expressed by macrophages
10. New nomenclature for the human tissue kallikrein gene family
11. Prostate specific antigen its usefulness in clinical medicine
12. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate
13. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression
14. Protease/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues and is hormonally regulated
15. Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expended human kallikrein gene family duster on chromosome 19q13.3-13.4
16. Prostate-specific antigen: A cancer fighter and a valuable messenger?
17. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus non-malignant prostatic tissue
18. Prostate-specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
19. Serum total and free prostate specific antigen for breast cancer diagnosis in women
20. The diagnostic and prognostic utility of prostate specific antigen for diseases of the breast
21. Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma
22. Elevated serum prostate-specific antigen levels in a woman with metastatic breast cancer
23. Prognostic value of prostate-specific antigen for women with breast cancer: A large US cohort study
24. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
25. Immunohistochemical localization of prostate specific antigen in benign and malignant breast tissues
26. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen
27. Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2
28. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic 'gray zone' of total PSA 4 to 10 ng/mL
29. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA
30. Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen
31. Human glandular kallikreins 2: A potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
32. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker
33. Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases
34. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction
35. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumors and in normal breast secretions
36. Human glandular kallikrein in breast milk, amniotic fluid and breast cyst fluid
37. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids
38. Human glandular kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
39. A novel protease homolog differentially expressed in breast and ovarian cancer
40. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain
41. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
42. Human kallikrein 6 (zyme/protease (zyfne/protease M/neurosin): A new serum biomarker of ovarian carcinoma
43. Human kallikrein 6 as a biomarker of Alzheimer's disease
44. Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa
45. Stratum comeum chymotryptic enzyme in psoriasis
46. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly over-expressed in ovarian tumor cells
47. Nervous system-specific expression of a novel serine protease: Regulation in the adult rat spinal cord by excitotoxic injury
48. Kindling induces neuropsin mRNA in the mouse brain
49. Blockage of neuropsin, a serine protease, ameliorates kindling epilepsy
50. The human KLK8 (neuropsin/ovasin) gene: Identification of two novel splice variants and its prognostic value in ovarian cancer
51. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression
52. The role for NES 1 serine. Protease as a novel tumor suppressor
53. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues
54. Human kallikrein 10: A noval tumor marker for ovarian carcinoma?
55. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumor suppressor gene in normal and malignant testicular tissue
56. KLK12 is a novel serine protease and a new member of the human kallikrein gene family - Differential expression in breast cancer
57. Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues
58. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies
59. Molecular doning of the human kallikrein 15 gene (KLK15): Upregulation in prostate cancer